Vir is leveraging immunologic breakthroughs to address unmet patient needs in infectious disease and beyond. Backed by SoftBank VF.
About the role
Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. Its clinical-stage portfolio includes programs for chronic hepatitis delta and multiple PRO-XTEN ® dual-masked T-cell engagers across validated targets in solid tumor indications. Vir Biotechnology also has a preclinical portfolio of programs across a range of infectious diseases and oncologic malignancies.
What they're looking for
- Hands-on analytical lab support for process development, formulation development, analytical methods development, and product characterization for projects at various clinical stages
- Perform all relevant analytical testing and report results in collaboration with the process development and drug product teams
- Apply mass spectrometry techniques and other analytical methods to support characterization of Vir products
- Stay current with emerging trends in protein or oligonucleotide analytics and introduce new technology to enhance workflow and capabilities
- Work cross-functionally within CMC with process and formulation development, QC and QA to meet program deliverables
- Perform forced degradation, comparability, structure-activity relationship studies to evaluate Vir products (e.g., for aggregation, charge variants, post-translational modifications, etc.), and perform CQA assessments
More about this role
Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. Its clinical-stage portfolio includes programs for chronic hepatitis delta and multiple PRO-XTEN ® dual-masked T-cell engagers across validated targets in solid tumor indications. Vir Biotechnology also has a preclinical portfolio of programs across a range of infectious diseases and oncologic malignancies.
Vir Biotechnology has exclusive rights to the universal PRO-XTEN ® masking platform for oncology and infectious disease. PRO-XTEN ® is a trademark of Amunix Pharmaceuticals, Inc., a Sanofi company.
We believe the success of our colleagues drives the success of our mission. We are committed to creating a company where everyone feels supported and encouraged to give their best.
THE OPPORTUNITY
Vir Biotechnology seeks a Temporary Staff analytical chemist to support the characterization of therapeutic molecules across a broad modality of products at various clinical stages. The successful candidate will be responsible for supporting the operation of analytical development...
Browse similar: Startup jobs · San Francisco Bay Area